Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Pneumococcal Disease, Protection Against”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Post-approval studies (Phase 4)Study completedNCT03489018
What this trial is testing

The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants

Who this might be right for
Pneumococcal InfectionStreptococcus Pneumoniae InfectionInvasive Pneumococcal Disease, Protection Against
London School of Hygiene and Tropical Medicine 2,100
Not applicableStudy completedNCT03815357
What this trial is testing

What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?

Who this might be right for
Invasive Pneumococcal Disease, Recurrent Isolated, 1Invasive Pneumococcal Disease, Recurrent Isolated, 2Invasive Pneumococcal Disease, Protection Against+1 more
Murdoch Childrens Research Institute 380
Not applicableUnknownNCT01694329
What this trial is testing

Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada

Who this might be right for
Acute Upper Respiratory InfectionAcute Lower Respiratory Tract InfectionOtitis Media (OM)+1 more
CHU de Quebec-Universite Laval 1,420
Large-scale testing (Phase 3)Study completedNCT03384589
What this trial is testing

CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study

Who this might be right for
Invasive Pneumococcal Disease, Protection AgainstStreptococcus Pneumoniae Infection
University of British Columbia 248